Panacea Life Sciences Holdings, Inc. Proceeds from Stock Options Exercised
Panacea Life Sciences Holdings, Inc. (PLSH) reported Proceeds from Stock Options Exercised of $6.00 thousand for the 12-month period ending 2020-12-31, per its 10-K/A filed 2021-04-23.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromStockOptionsExercised · last filed 2021-04-23
- Panacea Life Sciences Holdings, Inc. proceeds from stock options exercised for the quarter ending 2020-12-31 was $0.00.
- Panacea Life Sciences Holdings, Inc. proceeds from stock options exercised for the quarter ending 2019-12-31 was $0.00.
- Panacea Life Sciences Holdings, Inc. proceeds from stock options exercised for fiscal 2020 was $6.00K.
- Panacea Life Sciences Holdings, Inc. proceeds from stock options exercised for fiscal 2019 was $0.00.
| Period end | Proceeds from Stock Options Exercised 3 month | Proceeds from Stock Options Exercised 9 month | Proceeds from Stock Options Exercised 12 month |
|---|---|---|---|
| 2020-12-31 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2021-04-23 | $6.00K 10-K/A · filed 2021-04-23 | |
| 2020-09-30 | $6.00K 10-Q · filed 2020-11-18 | ||
| 2019-12-31 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2021-04-23 | $0.00 10-K/A · filed 2021-04-23 | |
| 2019-09-30 | $0.00 10-Q · filed 2020-11-18 |